Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology

PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance

  1. Michèle Guerre-Millo1,
  2. Christine Rouault2,
  3. Philippe Poulain3,
  4. Jocelyne André1,
  5. Vincent Poitout4,
  6. Jeffrey M. Peters5,
  7. Frank J. Gonzalez5,
  8. Jean-Charles Fruchart3,
  9. Gérard Reach2 and
  10. Bart Staels3
  1. 1Unit 465, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
  2. 2Unit 341, INSERM, Hôtel-Dieu, Paris, France
  3. 3Unit 545, INSERM, Département d’Athérosclérose, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France
  4. 4Pacific Northwest Research Institute and the Department of Medicine, University of Washington, Seattle, Washington
  5. 5Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland
    Diabetes 2001 Dec; 50(12): 2809-2814. https://doi.org/10.2337/diabetes.50.12.2809
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • FIG. 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 1.

      Effect of high-fat feeding on plasma glucose and insulin. Plasma glucose and insulin concentrations were measured in blood obtained from the orbital sinus of mice that had been food-deprived for 4 h. Wild-type and PPAR-α–null Sv/129 mice were fed either standard diet (□; n = 8 per genotype) or high-fat diet (▪; n = 8 per genotype) for 22 weeks. Data represent mean ± SE. *P < 0.01 versus standard diet.

    • FIG. 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 2.

      Relationship between leptin and adipose tissue weight. Plasma leptin was plotted against the epididymal adipose tissue weight for wild-type (triangles) and PPAR-α–null (circles) Sv/129 and C57BL/6 mice, fed either standard diet (open symbols) or high-fat diet (closed symbols).

    • FIG. 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 3.

      Effect of high-fat feeding on ITT. Intraperitoneal ITTs were performed in Sv/129 wild-type (○) and PPAR-α–null (•) mice fed either standard or high-fat diet for 22 weeks. Data are expressed relative to time 0 and represent the means ± SE of seven independent tests. Response curves were compared by two-way analysis of variance. The diet effect was statistically significant (P < 0.01) in wild-type mice. The genotype effect was statistically significant (P < 0.05) in high-fat–fed mice.

    • FIG. 4.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 4.

      Effect of high-fat feeding on GTT. Intraperitoneal GTTs were performed in Sv/129 wild-type (○) and PPAR-α–null (•) mice fed either standard or high-fat diet for 22 weeks. Data are expressed as changes relative to time 0 and represent the means ± SE of five independent tests.

    • FIG. 5.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 5.

      Insulin secretion in isolated islets. Insulin secretion was measured in static incubations of isolated islets from wild-type and PPAR-α–null mice on the C57BL/6N genetic background fed standard diet (□) or high-fat diet (▪) for 16 weeks. Data are the means ± SE of three (high-fat diet) and five (standard diet) separate incubations.

    Tables

    • Figures
    • TABLE 1

      Effect of long-term high-fat feeding in wild-type and PPAR-α–null mice on two genetic backgrounds

      C57BL/6N mice
      Sv/129 mice
      Wild-type
      PPAR-α–null
      Wild-type
      PPAR-α–null
      Standard diet (n = 6)High-fat diet (n = 6)Standard diet (n = 6)High-fat diet (n = 6)Standard diet (n = 8)High-fat diet (n = 8)Standard diet (n = 8)High-fat diet (n = 8)
      Food intake (kcal · kg−1 · day−1)465 ± 28.5511 ± 15.2506 ± 21.0560 ± 28.9383 ± 7.35414 ± 13.3369 ± 11.6386 ± 22.4
      Body weight (g)32.7 ± 0.9538.0 ± 1.37†30.8 ± 0.9432.4 ± 0.7827.1 ± 0.8034.5 ± 1.28†29.6 ± 0.7033.1 ± 0.90
      Liver weight (g)1.46 ± 0.121.44 ± 0.101.50 ± 0.071.48 ± 0.111.00 ± 0.031.26 ± 0.05†1.26 ± 0.081.95 ± 0.10†
      Adiposity index* (%)1.60 ± 0.333.58 ± 0.34†1.71 ± 0.253.74 ± 0.40†2.94 ± 0.236.34 ± 0.78†3.42 ± 0.365.93 ± 0.52†
      Plasma glucose (mmol/l)9.8 ± 0.6711.5 ± 0.7510.6 ± 0.729.3 ± 0.429.6 ± 0.5611.6 ± 0.589.1 ± 0.418.2 ± 0.65
      Plasma insulin (pmol/l)209 ± 21.3398 ± 50.1†189 ± 31.8225 ± 30.2215 ± 23.9378 ± 38.8†284 ± 26.9256 ± 32.3
      • Data are means ± SE. Mice on the C 57BL/6N genetic background were fed the high-fat diet for 16 weeks. Mice on the Sv/129 genetic background were fed the high-fat diet for 22 weeks.

      • *

        * Adiposity index was the ratio of epididymal adipose tissue to body weight for C57BL/6N mice and the ratio of epididymal + inguinal adipose tissue to body weight for Sv/129 mice.

      • †

        † P < 0.05 versus standard diet.

    • TABLE 2

      Effect of high-fat feeding on IR index

      Wild-type
      PPAR-α–null
      Standard diet (n = 5)High-fat diet (n = 5)Standard diet (n = 6)High-fat diet (n = 5)
      AUC glucose (mg/dl · 2 h)115 ± 15296 ± 78*106 ± 16128 ± 27
      AUC insulin (ng/dl · 2 h)17.3 ± 3.127.6 ± 2.7*23.2 ± 6.312.8 ± 2.5
      IR Index (AUC glucose · AUC insulin)1,970 ± 4138,400 ± 2,790*2,490 ± 7301,680 ± 548
      • Data are means ± SE. Areas under the insulin and glucose curves were calculated from the data shown in Fig. 4. The IR index is the product of glucose and insulin AUCs.

      • *

        * P < 0.05 versus standard diet.

    PreviousNext
    Back to top

    In this Issue

    December 2001, 50(12)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
    Michèle Guerre-Millo, Christine Rouault, Philippe Poulain, Jocelyne André, Vincent Poitout, Jeffrey M. Peters, Frank J. Gonzalez, Jean-Charles Fruchart, Gérard Reach, Bart Staels
    Diabetes Dec 2001, 50 (12) 2809-2814; DOI: 10.2337/diabetes.50.12.2809

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
    Michèle Guerre-Millo, Christine Rouault, Philippe Poulain, Jocelyne André, Vincent Poitout, Jeffrey M. Peters, Frank J. Gonzalez, Jean-Charles Fruchart, Gérard Reach, Bart Staels
    Diabetes Dec 2001, 50 (12) 2809-2814; DOI: 10.2337/diabetes.50.12.2809
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice
    • Longitudinal Assessment of 11C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes
    • Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy
    Show more Pathophysiology

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.